The National Comprehensive Cancer Network has announced that it has updated its practice guidelines for physicians to stress active surveillance rather than treatment for many men with low-risk prostate cancer.
Roswell Park Cancer Institute played a key role in the new recommendations, with three physicians serving on the network’s 23-member guideline panel, including Dr. James Mohler, who led the group.
A big change in the guidelines is the recommendation for active surveillance instead of treatment for men with very-low- risk prostate cancer and a life expectancy estimated at less than 20 years, and for men with low-risk prostate cancer and a life expectancy of less than 10 years.
The very-low-risk category is new and represents patients with what’s considered “insignificant” prostate cancer.
The new guidelines reflect the debate in medical circles over what is the most appropriate action to take with early-stage prostate cancer.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment